Reply to Supady et al. Comment on: Extracorporeal hemoadsorption in critically ill COVID-19 patients on VV ECMO: the CytoSorb therapy in COVID-19 (CTC) registry

Detalles Bibliográficos
Autor principal: Hayanga, J. W. Awori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10621176/
https://www.ncbi.nlm.nih.gov/pubmed/37919758
http://dx.doi.org/10.1186/s13054-023-04678-1
_version_ 1785130360274681856
author Hayanga, J. W. Awori
author_facet Hayanga, J. W. Awori
author_sort Hayanga, J. W. Awori
collection PubMed
description
format Online
Article
Text
id pubmed-10621176
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-106211762023-11-03 Reply to Supady et al. Comment on: Extracorporeal hemoadsorption in critically ill COVID-19 patients on VV ECMO: the CytoSorb therapy in COVID-19 (CTC) registry Hayanga, J. W. Awori Crit Care Correspondence BioMed Central 2023-11-02 /pmc/articles/PMC10621176/ /pubmed/37919758 http://dx.doi.org/10.1186/s13054-023-04678-1 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Correspondence
Hayanga, J. W. Awori
Reply to Supady et al. Comment on: Extracorporeal hemoadsorption in critically ill COVID-19 patients on VV ECMO: the CytoSorb therapy in COVID-19 (CTC) registry
title Reply to Supady et al. Comment on: Extracorporeal hemoadsorption in critically ill COVID-19 patients on VV ECMO: the CytoSorb therapy in COVID-19 (CTC) registry
title_full Reply to Supady et al. Comment on: Extracorporeal hemoadsorption in critically ill COVID-19 patients on VV ECMO: the CytoSorb therapy in COVID-19 (CTC) registry
title_fullStr Reply to Supady et al. Comment on: Extracorporeal hemoadsorption in critically ill COVID-19 patients on VV ECMO: the CytoSorb therapy in COVID-19 (CTC) registry
title_full_unstemmed Reply to Supady et al. Comment on: Extracorporeal hemoadsorption in critically ill COVID-19 patients on VV ECMO: the CytoSorb therapy in COVID-19 (CTC) registry
title_short Reply to Supady et al. Comment on: Extracorporeal hemoadsorption in critically ill COVID-19 patients on VV ECMO: the CytoSorb therapy in COVID-19 (CTC) registry
title_sort reply to supady et al. comment on: extracorporeal hemoadsorption in critically ill covid-19 patients on vv ecmo: the cytosorb therapy in covid-19 (ctc) registry
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10621176/
https://www.ncbi.nlm.nih.gov/pubmed/37919758
http://dx.doi.org/10.1186/s13054-023-04678-1
work_keys_str_mv AT hayangajwawori replytosupadyetalcommentonextracorporealhemoadsorptionincriticallyillcovid19patientsonvvecmothecytosorbtherapyincovid19ctcregistry

Ejemplares similares